4//SEC Filing
LAUDER RONALD S 4
Accession 0001001250-21-000037
CIK 0001001250other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 6:40 PM ET
Size
20.9 KB
Accession
0001001250-21-000037
Insider Transaction Report
Form 4
LAUDER RONALD S
Chairman, Clinique Labs, LLC10% Owner
Transactions
- Sale
Class A Common Stock
2021-03-03$289.48/sh−17,800$5,152,744→ 342,200 total - Sale
Class A Common Stock
2021-03-03$291.36/sh−61,005$17,774,417→ 222,794 total - Sale
Class A Common Stock
2021-03-03$292.45/sh−87,521$25,595,516→ 135,273 total - Conversion
Class A Common Stock
2021-03-02+406,000→ 406,000 total - Gift
Class A Common Stock
2021-03-02−36,000→ 370,000 total - Sale
Class A Common Stock
2021-03-03$293.10/sh−56,902$16,677,976→ 78,371 total - Gift
Class A Common Stock
2021-03-02−10,000→ 360,000 total - Sale
Class A Common Stock
2021-03-03$290.55/sh−58,401$16,968,411→ 283,799 total - Conversion
Class B Common Stock
2021-03-02−406,000→ 7,168,846 total→ Class A Common Stock (406,000 underlying)
Holdings
- 6,364(indirect: By Trust)
Class A Common Stock
- 6,364(indirect: By Trust)
Class B Common Stock
→ Class A Common Stock (6,364 underlying)
Footnotes (10)
- [F1]Ronald S. Lauder ("RSL") converted shares of Class B Common Stock into an equal number of shares of Class A Common Stock.
- [F10]RSL disclaims beneficial ownership of these shares to the extent he does not have a pecuniary interest in such securities.
- [F2]There is no exercise or conversion price for the Class B Common Stock. Shares of Class B Common Stock (i) may be converted immediately on a one-for-one basis by the holder into shares of Class A Common Stock and (ii) are automatically converted into Class A Common Stock on a one-for-one basis upon transfer to a person or entity that is not a "Permitted Transferee" (as defined in Issuer's Restated Certificate of Incorporation) or soon after a record date for a meeting of stockholders where the outstanding Class B Common Stock constitutes less than 10% of the outstanding shares of Common Stock of the Issuer.
- [F3]Not applicable.
- [F4]The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- [F5]Sales prices range from $288.93 to $289.91 per share, inclusive.
- [F6]Sales prices range from $289.94 to $290.93 per share, inclusive.
- [F7]Sales prices range from $290.94 to $291.93 per share, inclusive.
- [F8]Sales prices range from $291.94 to $292.93 per share, inclusive.
- [F9]Sales prices range from $292.94 to $293.58 per share, inclusive.
Documents
Issuer
ESTEE LAUDER COMPANIES INC
CIK 0001001250
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0000942617
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 6:40 PM ET
- Size
- 20.9 KB